Search Results

Displaying Results 7676-7700 of 7956 "'EU'"

Oct 27, 2025, 03:42 ET Xinhua Silk Road: 중국 랑주, 이탈리아에서 '중국 랑주, 세계를 맞이하다' 행사 개최

multimedia:https://www.prnewswire.com/kr/news-releases/u0078u0069u006Eu0068u0075u0061u002Du0073u0069u006Cu006Bu002Du0072u006Fu0061u0064u003Au002DuC911uAD6Du002DuB791uC8FCu002Cu002DuC774uD0C8uB9AC-302595097.html

More news about: Xinhua Silk Road


Oct 27, 2025, 03:00 ET Business Sentiment Softens in Q4 Amid Global Uncertainty, while Domestic Orders Show Continued Resilience

(despite their exposure to US tariffs). This is being supported by India's diversification efforts, as it is negotiating trade deals and agreements with the EU (expected by the end of December 2025), Netherlands, New Zealand, Oman, Peru, Chile and the Eurasian Economic Union (EAEU). While US tariffs are expected

More news about: Dun & Bradstreet India


Oct 27, 2025, 02:40 ET ZICC: A Bridge of Promise

trading partner for China within the EU, and Bruges, the capital of West Flanders, derives its name from the Flemish word for "bridge". In 2014, Chinese President Xi Jinping delivered an important speech at the College of Europe in Bruges, injecting new energy into China-EU relations and strengthening the

More news about: ZICC


Oct 27, 2025, 01:00 ET EU Climate Ambitions at Risk Flawed Regulatory Framework Threatens Shipping Innovation

Undermining EU competitiveness The European Commission's regulatory failures, alongside EU Member State product approval bottlenecks, have prevented Selektope®-based products from reaching the EU market despite its full approval under the EU BPR since 2016.

More news about: I-Tech


Oct 27, 2025, 01:00 ET EU Climate Ambitions at Risk Flawed Regulatory Framework Threatens Shipping Innovation

Undermining EU competitiveness The European Commission's regulatory failures, alongside EU Member State product approval bottlenecks, have prevented Selektope®-based products from reaching the EU market despite its full approval under the EU BPR since 2016.

More news about: I-Tech


Oct 27, 2025, 01:00 ET EU-Klimaziele in Gefahr - Unzulänglicher Rechtsrahmen gefährdet Innovationen in der Schifffahrt

Wettbewerbsfähigkeit der EU Die regulatorischen Versäumnisse der Europäischen Kommission sowie Engpässe bei der Produktzulassung in den EU-Mitgliedstaaten haben dazu geführt, dass Produkte auf Selektope®-Basis trotz ihrer vollständigen Zulassung gemäß der EU-BPR seit 2016

More news about: I-Tech


Oct 26, 2025, 22:58 ET Health Canada Grants Authorization for Leqembi® (lecanemab)

against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Lecanemab is approved in the U.S., Japan, EU, China, Great Britain, and several other markets for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD dementia.

More news about: BioArctic


Oct 26, 2025, 22:56 ET Health Canada Grants Authorization for Leqembi® (lecanemab)

against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Lecanemab is approved in the U.S., Japan, EU, China, Great Britain, and several other markets for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD dementia.

More news about: BioArctic


Oct 26, 2025, 20:00 ET 가이드포인트, AI Moderation 출시: 전문가 인사이트를 더 빠르고 효과적으로

content:https://www.prnewswire.com/kr/news-releases/uAC00uC774uB4DCuD3ECuC778uD2B8u002Cu002Du0061u0069u002Du006Du006Fu0064u0065u0072u0061u0074u0069u006Fu006Eu002DuCD9CuC2DCu003Au002DuC804uBB38-302593895.html

More news about: Guidepoint


Oct 26, 2025, 16:56 ET Ribo kriegt von der EMA den Status als Orphan Drug für das siRNA-Therapeutikum RBD1016 gegen Hepatitis-Delta-Virus-Infektion (HDV)

neue Therapien gegen lebensbedrohliche oder chronisch schwächende seltene Krankheiten vergeben, von denen nicht mehr als fünf von 10.000 Menschen in der EU betroffen sind. Der ODD-Status bietet erhebliche regulatorische und kommerzielle Anreize und ermöglicht so eine schnellere Entwicklung zum Patienten.

More news about: Ribo Life Science


Oct 26, 2025, 01:31 ET CGTN: 대만의 역사를 복원하다

multimedia:https://www.prnewswire.com/kr/news-releases/u0063u0067u0074u006Eu003Au002DuB300uB9CCuC758u002DuC5EDuC0ACuB97Cu002DuBCF5uC6D0uD558uB2E4-302594590.html

More news about: CGTN


Oct 24, 2025, 18:32 ET Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies

2024 and for Sjögren's disease in November 2024 U.S. FDA granted Priority Review in gMG in Q4 2024 EU EMA Orphan medicinal product designation for HDFN in October 2019 and FNAIT in April 2025 The legal manufacturer

More news about: Johnson & Johnson


Oct 24, 2025, 13:23 ET Shanghai Electric signe la phase II du projet photovoltaïque de 342 MW de Parau avec Econergy, soutenant ainsi l'avenir vert de la Roumanie

pour développer conjointement des projets d'énergie renouvelable », a déclaré Istvan-Lorant Antal. M. Wu Lei a également eu des entretiens de haut niveau avec des cadres d'OMV Group d'Autriche afin d'explorer de nouvelles opportunités de coopération dans le secteur

More news about: Shanghai Electric


Oct 24, 2025, 12:14 ET Procedimentos estéticos injetáveis: quando é o momento certo para começar?

pele nas redes sociais, também defende um olhar mais consciente quando se trata de procedimentos estéticos. "Cada pessoa tem seu tempo e seus motivos. Eu, por exemplo, optei por fazer preenchimento labial porque queria valorizar uma área que já gosto muito em mim: minha boca. Senti que o procedimento trouxe

More news about: Galderma


Oct 24, 2025, 10:20 ET Hope in Syria: Education Cannot Wait investments support teacher training and continued learning for displaced children in Syria

crises within the United Nations, is reaching Rudayfah and her students at the UNICEF-run school in the camp. ECW investments – along with funding from EU Humanitarian Aid, the Foreign Commonwealth and Development Office, German Federal Ministry for Economic Cooperation and Development through the KFW Development

More news about: Education Cannot Wait


Oct 24, 2025, 09:56 ET Hope in Syria: Education Cannot Wait investments support teacher training and continued learning for displaced children in Syria

crises within the United Nations, is reaching Rudayfah and her students at the UNICEF-run school in the camp. ECW investments – along with funding from EU Humanitarian Aid, the Foreign Commonwealth and Development Office, German Federal Ministry for Economic Cooperation and Development through the KFW Development

More news about: Education Cannot Wait


Oct 24, 2025, 08:36 ET Tobias Nyhuus Jensen von Siteimprove zum nationalen Experten für Dänemark in der AccessibleEU-Initiative der Europäischen Kommission ernannt

Accessible EU bringt Experten aus ganz Europa zusammen, um das Bewusstsein für Barrierefreiheit, den Wissensaustausch und die Zusammenarbeit

More news about: Siteimprove


Oct 24, 2025, 08:30 ET Maximum Fair Price Strategies for IPAY2027 Readiness, Upcoming Webinar Hosted by Xtalks

Director; and Taylor Schwartz, Evidence & Strategy Managing Director, for the live webinar on Monday, November 10, 2025, at 11am EST (5pm CET/EU-Central). For more information, or to register for this event, visit 

More news about: Xtalks


Oct 24, 2025, 04:00 ET Renalys Pharma to be Acquired by Chugai Pharmaceutical

proteinuria, preservation of kidney function and a well-tolerated safety profile compared with active control irbesartan. In Europe, FILSPARI® received standard EU approval for the IgA nephropathy indication in 2025. In 2025, the FDA accepted for review Travere's supplemental new drug application (sNDA) for FILSPARI®

More news about: Renalys Pharma, Inc.


Oct 24, 2025, 03:07 ET Euroclear builds on strong momentum in Q3 2025

to gradual rate cuts. Future interest earnings will continue to evolve in line with future policy rates. As required by the EU windfall contribution regulation, Euroclear provisioned €2.6 billion as windfall contribution for YTD 2025, of which €1.6 billion has been paid to the

More news about: Euroclear


Oct 24, 2025, 03:02 ET Euroclear builds on strong momentum in Q3 2025

to gradual rate cuts. Future interest earnings will continue to evolve in line with future policy rates. As required by the EU windfall contribution regulation, Euroclear provisioned €2.6 billion as windfall contribution for YTD 2025, of which €1.6 billion has been paid to the

More news about: Euroclear


Oct 24, 2025, 02:41 ET Xinhua Silk Road: 중국 주류 제조사 우량예, 2025 EFQM 글로벌 어워드 수상

multimedia:https://www.prnewswire.com/kr/news-releases/u0078u0069u006Eu0068u0075u0061u002Du0073u0069u006Cu006Bu002Du0072u006Fu0061u0064u003Au002DuC911uAD6Du002DuC8FCuB958u002DuC81CuC870uC0ACu002D-302593674.html

More news about: Xinhua Silk Road


Oct 24, 2025, 02:14 ET Hexagon Interim Report 1 January - 30 September 2025

[email protected] This is information that Hexagon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on 24 October

More news about: Hexagon


Oct 24, 2025, 01:55 ET Munters Group AB: Strong performance driven by growth in key industries

(0)702 067 786 This information is information that Munters Group AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07.30 CEST on October

More news about: Munters Group AB


Oct 24, 2025, 01:48 ET Saab Q3 2025 results: Delivering sustained growth

nations. The information is such that Saab AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 24 October 2025 at

More news about: Saab


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.